Xenetic Biosciences Inc XBIO:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
Last | 1:39 PM EDT
4.14quote price arrow down-1.16 (-21.89%)
Volume
12,539,206
52 week range
0.76 - 5.85

...

Loading . . .
  • Open4.46
  • Day High4.97
  • Day Low4.03
  • Prev Close5.30
  • 52 Week High5.85
  • 52 Week High Date12/09/20
  • 52 Week Low0.76
  • 52 Week Low Date11/02/20

Key Stats

  • Market Cap36.22M
  • Shares Out8.75M
  • 10 Day Average Volume50.12M
  • Dividend-
  • Dividend Yield-
  • Beta2.67
  • YTD % Change104.9

KEY STATS

  • Open4.46
  • Day High4.97
  • Day Low4.03
  • Prev Close5.30
  • 52 Week High5.85
  • 52 Week High Date12/09/20
  • 52 Week Low0.76
  • 52 Week Low Date11/02/20
  • Market Cap36.22M
  • Shares Out8.75M
  • 10 Day Average Volume50.12M
  • Dividend-
  • Dividend Yield-
  • Beta2.67
  • YTD % Change104.9

RATIOS/PROFITABILITY

  • EPS (TTM)-1.68
  • P/E (TTM)-2.46
  • Fwd P/E (NTM)-8.28
  • EBITDA (MRQ)-4.832M
  • ROE (MRQ)-81.50%
  • Revenue (MRQ)570,000.00
  • Gross Margin (MRQ)100.00%
  • Net Margin (MRQ)-1,935.56%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date08/12/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Xenetic Biosciences Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Xenetic Biosciences, Inc. is a biopharmaceutical company. The Company is focused on progressing XCART, a personalized chimeric antigen receptor (CAR) T platform technology engineered to target patient-specific tumor neoantigens. The Company is advancing cell-based therapeutics targeting the B-cell receptor on the surface of an individual patient’s malignant tumor cells for the treatment of B-cell lymphomas. The Company is leveraging PolyXen, its drug delivery platform, by...
Jeffrey Eisenberg
Chief Executive Officer
James Parslow
Chief Financial Officer
Address
40 Speen St Ste 102
Framingham, MA
01701-1898
United States

Top Peers

SYMBOLLASTCHG%CHG
BLCM
Bellicum Pharmaceuticals Inc
3.02+0.04+1.34%
EYEG
EyeGate Pharmaceuticals Inc
2.58-0.32-11.03%
ARTL
Artelo Biosciences Inc
1.02-0.01-0.97%
TPST
Tempest Therapeutics Inc
15.16-0.32-2.07%
PHIO
Phio Pharmaceuticals Corp
1.80-0.01-0.82%